paclitaxel has been researched along with Chemotherapy-Induced Febrile Neutropenia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, J; Beca, JM; Berry, SR; Biagi, JJ; Chan, KKW; Cheng, S; Coburn, N; Dai, WF; Earle, C; Gavura, S; Guo, H; Isaranuwatchai, W; Kennedy, ED; McLeod, R; Meyers, BM; Mittmann, N; Qiao, L; Redmond-Misner, R; Schwartz, D; Welch, S | 1 |
| Cha, J; Hsu, S; Huang, S; Jennings, E; Lee, JB | 1 |
| Geyer, CE; Golshan, M; Huober, J; Liu, X; Loibl, S; Maag, D; McIntyre, K; McKee, MD; Metzger Filho, O; O'Shaughnessy, J; Ponce Lorenzo, JJ; Rastogi, P; Rugo, HS; Sikov, WM; Sullivan, D; Symmans, WF; Untch, M; von Minckwitz, G; Wolmark, N | 1 |
| Buckley, B; Caffrey, PB; Frenkel, GD; Gibbon, DG; Gounder, M; Hellmann, M; Kane, MP; Kumaran, MN; Nieves-Neira, W; Rodriguez-Rodriguez, L; Shih, W; Song, M; Vaidya, A | 1 |
| Arance, A; Conti, I; Garbe, C; Grob, JJ; Hahka-Kemppinen, M; Hamid, O; Hauschild, A; Hutson, TE; Ilaria, R; Kaiser, C; Lee, J; Lorigan, P; Maio, M; Mohr, P; Turner, PK; Wolter, P | 1 |
| Carlson, DM; Horai, T; Horiike, A; Horinouchi, H; Kaneda, H; McKee, MD; Nakagawa, K; Nishio, M; Nokihara, H; Ohyanagi, F; Okabe, T; Tamura, T; Terashima, M; Xiong, H; Yamamoto, N | 1 |
| Arnould, L; Bonnetain, F; Borg, C; Cleau, D; El Gani, M; Fein, F; Fratté, S; Ghiringhelli, F; Jacquin, M; Jary, M; Kim, S; Lamfichekh, N; Lassabe, C; Mathieu, P; Nerich, V; Nguyen, T; Paget-Bailly, S; Valmary-Degano, S | 1 |
| Aisner, J; Aisner, S; Dahlberg, SE; DiPaola, RS; Pillai, RN; Ramalingam, SS; Rogers, JS; Schiller, JH | 1 |
| Koo, YJ; Lim, KT | 1 |
| Bafna, UD; Devi, UK; Kundargi, R; Pallavi, VR; Rathod, PS; Vijay, CR | 1 |
| Aloisi, A; Angioli, R; Capriglione, S; Fiore, L; Luvero, D; Montera, R; Panici, PB; Plotti, F; Scaletta, G; Terranova, C | 1 |
| Copur, MS; DeSpiegelaere, H; Ganti, AK; Huerter, MM; Kessinger, A; Ketcham, M; Kos, ME; Kruse, S; Marr, AS; Meza, JL; Radniecki, SE; Swenson, K; Tolentino, A | 1 |
| Capelan, M; Lote, H; Mohammed, K; Papadimitraki, E; Redana, S; Ring, A; Sharp, A | 1 |
| Bergmann, TK; Brasch-Andersen, C; Brøsen, K; Damkier, P; Gréen, H; Keldsen, N; Mirza, MR; Peterson, C; Skougaard, K; Vach, W; Wihl, J | 1 |
8 trial(s) available for paclitaxel and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Double-Blind Method; Doxorubicin; Female; Genes, BRCA1; Genes, BRCA2; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Mutation; Neoadjuvant Therapy; Paclitaxel; Survival Rate; Thrombocytopenia; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden | 2018 |
Phase I trial of selenium plus chemotherapy in gynecologic cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Chemotherapy-Induced Febrile Neutropenia; DNA-Binding Proteins; Down-Regulation; Female; Gene Expression; Glutathione Peroxidase; Humans; Infections; Lung Diseases; Maximum Tolerated Dose; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Response Evaluation Criteria in Solid Tumors; RNA-Binding Proteins; Selenious Acid; Selenium; Selenoprotein P | 2018 |
A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chemotherapy-Induced Febrile Neutropenia; Disease-Free Survival; Drug Administration Schedule; Early Termination of Clinical Trials; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukopenia; Male; Melanoma; Middle Aged; Neoplasm Staging; Paclitaxel; Severity of Illness Index; Skin Neoplasms; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2014 |
A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Non-Small-Cell Lung; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Indazoles; Japan; Leukopenia; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Phenylurea Compounds; Protein Kinase Inhibitors; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Severity of Illness Index; Thrombocytopenia; Tumor Burden | 2014 |
Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Cohort Studies; Drug Monitoring; Epirubicin; Esophageal Neoplasms; Esophagus; Feasibility Studies; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pilot Projects; Severity of Illness Index; Stomach; Stomach Neoplasms; Survival Analysis | 2014 |
Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Small Cell; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Early Termination of Clinical Trials; Female; Follow-Up Studies; Humans; Interferon-alpha; Isotretinoin; Leukocytes, Mononuclear; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Severity of Illness Index; Small Cell Lung Carcinoma; Survival Analysis | 2014 |
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery.
Topics: Adenocarcinoma; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Radiography; Radionuclide Imaging; Survival Rate; Uterine Cervical Neoplasms | 2015 |
Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brain Ischemia; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy-Induced Febrile Neutropenia; Disease-Free Survival; Early Termination of Clinical Trials; Female; Heart Arrest; Humans; Hypoxia; Lung Neoplasms; Lymphopenia; Male; Neutropenia; Paclitaxel; Pneumonia; Quality of Life; Respiratory Insufficiency; Survival Rate; Tomography, X-Ray Computed; Vinblastine; Vinorelbine | 2017 |
6 other study(ies) available for paclitaxel and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis.
Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Deoxycytidine; Emergency Service, Hospital; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Hospitalization; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Ontario; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Propensity Score; Treatment Outcome | 2020 |
Toxic erythema of chemotherapy secondary to gemcitabine and paclitaxel.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Deoxycytidine; Erythema; Female; Gemcitabine; Humans; Intertrigo; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pancreatic Neoplasms | 2020 |
Toxicity of intraperitoneal chemotherapy and risk factors for severe toxicity in optimally debulked ovarian cancer patients.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Catheter Obstruction; Catheters, Indwelling; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cisplatin; Cytoreduction Surgical Procedures; Diarrhea; Disease-Free Survival; Female; Humans; Ileus; Infusions, Parenteral; Middle Aged; Nausea; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Risk Factors; Survival Rate; Vomiting; Withholding Treatment | 2015 |
Refractory Gestational Trophoblastic Neoplasia: A Novel Drug Combination With Paclitaxel and Carboplatin Produces Durable Complete Remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy-Induced Febrile Neutropenia; Chorionic Gonadotropin, beta Subunit, Human; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Mucositis; Paclitaxel; Pregnancy; Prospective Studies; Remission Induction; Retreatment; Salvage Therapy; Survival Rate; Thrombocytopenia | 2015 |
Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population.
Topics: Acute Coronary Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Incidence; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pulmonary Embolism; Retrospective Studies; Risk Factors; Sentinel Lymph Node Biopsy; Stroke; Taxoids; Thromboembolism; Venous Thrombosis | 2016 |
Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer.
Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; Chemotherapy-Induced Febrile Neutropenia; Cytochrome P-450 CYP2C8; Female; Genotyping Techniques; Humans; Middle Aged; Neutrophils; Ovarian Neoplasms; Paclitaxel; Patient Compliance; Pharmacogenetics; Polymorphism, Single Nucleotide; Prospective Studies; White People | 2012 |